Rapid Normalization of Amniotic Fluid Index Following Discontinuation of Olmesartan: A Case Report. [PDF]
Van Oosbree A +5 more
europepmc +1 more source
Activation of the angiotensin II type I receptor by a nonpeptide agonist. [PDF]
Skiba MA +12 more
europepmc +1 more source
Case Report: Neuropsychiatric and cognitive phenomena in a highly complex patient affected by psychiatric and oncological diseases. [PDF]
Borghesani A +8 more
europepmc +1 more source
Adverse Oral Mucosal Reaction to Sublingual Captopril: A Case Report With Exploratory Insights Into AI-Assisted Clinical Reasoning. [PDF]
JĂșnior ARG +6 more
europepmc +1 more source
Severe angioedema following dupilumab therapy for bullous pemphigoid. [PDF]
Mummareddy H, Han S, Shroyer W.
europepmc +1 more source
Risk factors for drug-related impaired gastric emptying: a pharmacovigilance analysis of the FDA adverse event reporting system. [PDF]
Chen JH +5 more
europepmc +1 more source
Drug-associated inflammatory bowel disease: a real-world pharmacovigilance study using the FAERS and JADER databases. [PDF]
Ying Y +8 more
europepmc +1 more source
Serine encodes drug selectivity in human OAT1. [PDF]
Dai Y, Lee CH.
europepmc +1 more source
Stability of Olmesartan Medoxomil Tablets in Unit-Dose Packaging With Metformin Hydrochloride Tablets. [PDF]
Ohashi R +8 more
europepmc +1 more source
Single-Pill Combination Olmesartan/Amlodipine/Hydrochlorothiazide Safety and Effectiveness in Older Patients with Hypertension: Pooled Analysis of Post-Approval Observational Studies. [PDF]
Kim HJ, Kim HM, Kim DH.
europepmc +1 more source

